The effect of edaravone on plasma monocyte chemoattractant protein-1 levels in patients with acute myocardial infarction

Journal of Cardiology

Volumn 54, Issue 3, 2009, Pages 416-424

  Nakamura, Yoshinori ^a   Yamada, Yoshihiro ^a   Shimomura, Hideki ^a   Nagayoshi, Yasuhiro ^b   Tsujita, Kenichi ^b   Yamashita, Takuro ^a   Fukuda, Masaya ^b   Ohba, Keisuke ^b   Nako, Hisato ^b   Ogura, Yuji ^a   Chitose, Tadasuke ^a   Yamaguchi, Munetaka ^a   Nagata, Takeshi ^a   Soejima, Hirofumi ^b   Kaikita, Koichi ^b   Sugiyama, Seigo ^b   Ogawa, Hisao ^b  

^a Fukuoka Tokushukai Hospital   (Japan)

^b KUMAMOTO UNIVERSITY   (Japan)

Author keywords

Antioxidants; Free radicals; Monocyte chemoattractant protein 1; Myocardial infarction; Reperfusion

Indexed keywords

ACETYLSALICYLIC ACID; CREATINE KINASE MB; HEPARIN; MONOCYTE CHEMOTACTIC PROTEIN 1; NORPHENAZONE; PLACEBO; TICLOPIDINE;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; BLOOD CLOTTING TIME; CARDIAC PATIENT; CLINICAL ARTICLE; CLINICAL EVALUATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY THROMBOSIS; CORONARY STENT; CREATINE KINASE BLOOD LEVEL; DRUG EFFECT; FEMALE; HEART ARRHYTHMIA; HEART DEATH; HEART FAILURE; HEART INFARCTION SIZE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART VENTRICLE TACHYCARDIA; HOSPITAL READMISSION; HUMAN; MALE; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; REPERFUSION; THROMBOSIS;

AGED; ANGIOPLASTY, BALLOON, CORONARY; ANTIPYRINE; BIOLOGICAL MARKERS; CHEMOKINE CCL2; FEMALE; FREE RADICAL SCAVENGERS; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION INJURY; PATIENT READMISSION; PROGNOSIS; STROKE VOLUME; VENTRICULAR FUNCTION, LEFT;

EID: 70450224259     PISSN: 09145087     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jjcc.2009.07.001     Document Type: Article

References (36)

1. McCord J.M. Oxygen-derived free radicals in post-ischemic tissue injury. N Engl J Med 312 (1985) 159-163
2. Murakami J., Toyama T., Adachi H., Hoshizaki H., Oshima S., and Kurabayashi M. Important factors for salvaging myocardium in patients with acute myocardial infarction. J Cardiol 52 (2008) 269-275
3. Ishihara M., Inoue I., Kawagoe T., Shimatani Y., Kurisu S., Nakama Y., Maruhashi T., Kagawa E., Dai K., Matsushita J., and Ikenaga H. Trends in gender difference in mortality after acute myocardial infarction. J Cardiol 52 (2008) 232-238
4. Entman M.L., and Smith C.W. Postreperfusion inflammation: a model for reaction to injury in cardiovascular disease. Cardiovasc Res 28 (1994) 1301-1311
5. Fishbein M.C., Maclean D., and Maroko P.R. The histopathologic evolution of myocardial infarction. Chest 73 (1978) 843-849
6. Murry C.E., Giachelli C.M., Schwartz S.M., and Vracko R. Macrophages express osteopontin during repair of myocardial necrosis. Am J Pathol 145 (1994) 1450-1462
7. Suzuki H., Wildhirt S.M., Dudek R.R., Narayan K.S., Bailey A.H., and Bing R.J. Induction of apoptosis in myocardial infarction and its possible relationship to nitric oxide synthase in macrophages. Tissue Cell 28 (1996) 89-97
8. Luster A.D. Chemokines-chemotactic cytokines that mediate inflammation. N Engl J Med 338 (1998) 436-445
9. Reape T.J., and Groot P.H. Chemokines and atherosclerosis. Atherosclerosis 147 (1999) 213-225
10. Ban K., Ikeda U., Takahashi M., Kanbe T., Kasahara T., and Shimada K. Expression of intercellular adhesion molecule-1 on rat cardiac myocytes by monocyte chemoattractant protein-1. Cardiovasc Res 28 (1994) 1258-1262
11. Kakio T., Matsumori A., Ono K., Ito H., Matsushima K., and Sasayama S. Roles and relationship of macrophages and monocyte chemotactic and activating factor/monocyte chemoattractant protein-1 in the ischemic and reperfused rat heart. Lab Invest 80 (2000) 1127-1136
12. Martinovic I., Abegunewardene N., Seul M., Vosseler M., Horstick G., Buerke M., Darius H., and Lindemann S. Elevated monocyte chemoattractant protein-1 serum levels in patients at risk for coronary artery disease. Circ J 69 (2005) 1484-1489
13. Kohno T., Anzai T., Naito K., Sugano Y., Maekawa Y., Takahashi T., Yoshikawa T., and Ogawa S. Angiotensin-receptor blockade reduces border zone myocardial monocyte chemoattractant protein-1 expression and macrophage infiltration in post-infarction ventricular remodeling. Circ J 72 (2008) 1685-1692
14. Hayasaki T., Kaikita K., Okuma T., Yamamoto E., Kuziel W.A., Ogawa H., and Takeya M. CC chemokine receptor-2 deficiency attenuates oxidative stress and infarct size caused by myocardial ischemia-reperfusion in mice. Circ J 70 (2006) 342-351
15. de Lemos J.A., Morrow D.A., Blazing M.A., Jarolim P., Wiviott S.D., Sabatine M.S., Califf R.M., and Braunwald E. Serial measurement of monocyte chemoattractant protein-1 after acute coronary syndromes: results from the A to Z trial. J Am Coll Cardiol 50 (2007) 2117-2124
16. Nishi H., Watanabe T., Sakurai H., Yuki S., and Ishibashi A. Effect of MCI-186 on brain edema in rats. Stroke 20 (1989) 1236-1240
17. Abe K., Yuki S., and Kogure K. Strong attenuation of ischemic and postischemic brain edema in rats by a novel free radical scavenger. Stroke 19 (1988) 480-485
18. Watanabe T., and Egawa M. Effect of an antistroke agent MCI-186 on cerebral arachidonate cascade. J Pharmacol Exp Ther 271 (1994) 1624-1629
19. Tsujita K., Shimomura H., Kawano H., Hokamaki J., Fukuda M., Yamashita T., Hida S., Nakamura Y., Nagayoshi Y., Sakamoto T., Yoshimura M., Arai H., and Ogawa H. Effects of edaravone on reperfusion injury in patients with acute myocardial infarction. Am J Cardiol 94 (2004) 481-484
20. Tsujita K., Shimomura H., Kaikita K., Kawano H., Hokamaki J., Nagayoshi Y., Yamashita T., Fukuda M., Nakamura Y., Sakamoto T., Yoshimura M., and Ogawa H. Long-term efficacy of edaravone in patients with acute myocardial infarction. Circ J 70 (2006) 832-837
21. Hayashidani S., Tsutsui H., Shiomi T., Ikeuchi M., Matsusaka H., Suematsu N., Wen J., Egashira K., and Takeshita A. Anti-monocyte chemoattractant protein-1 gene therapy attenuates left ventricular remodeling and failure after experimental myocardial infarction. Circulation 108 (2003) 2134-2140
22. Murakami Y., Kurosaki K., Matsui K., Shimada K., and Ikeda U. Serum MCP-1 and VEGF levels are not affected by inhibition of the renin-angiotensin system in patients with acute myocardial infarction. Cardiovasc Drugs Ther 17 (2003) 249-255
23. Ito W.D., Arras M., Winkler B., Scholz D., Schaper J., and Schaper W. Monocyte chemotactic protein-1 increases collateral and peripheral conductance after femoral artery occlusion. Circ Res 80 (1997) 829-837
24. Deindl E., Buschmann I., Hoefer I.E., Podzuweit T., Boengler K., Vogel S., van Royen N., Fernandez B., and Schaper W. Role of ischemia and of hypoxia-inducible genes in arteriogenesis after femoral artery occlusion in the rabbit. Circ Res 89 (2001) 779-786
25. Arras M., Ito W.D., Scholz D., Winkler B., Schaper J., and Schaper W. Monocyte activation in angiogenesis and collateral growth in the rabbit hind limb. J Clin Invest 101 (1998) 40-50
26. Shimomura H., Ogawa H., Takazoe K., Soejima H., Miyamoto S., Sakamoto T., Kawano H., Suefuji H., Nishikawa H., Arai H., Hokamaki J., Kajiwara I., Kugiyama K., and Yoshimura M. Comparison of urinary biopyrrin levels in acute myocardial infarction (after reperfusion therapy) versus stable angina pectoris and their usefulness in predicting subsequent cardiac events. Am J Cardiol 90 (2002) 108-111
27. Miyamoto S., Sakamoto T., Soejima H., Shimomura H., Kajiwara I., Kojima S., Hokamaki J., Sugiyama S., Yoshimura M., Ozaki Y., Nakamura H., Yodoi J., and Ogawa H. Plasma thioredoxin levels and platelet aggregability in patients with acute myocardial infarction. Am Heart J 146 (2003) 465-471
28. Soejima H., Suefuji H., Miyamoto S., Kajiwaram I., Kojima S., Hokamaki J., Sakamoto T., Yoshimura M., Nakamura H., Yodoi J., and Ogawa H. Increased plasma thioredoxin in patients with acute myocardial infarction. Clin Cardiol 26 (2003) 583-587
29. Nagayoshi Y., Kawano H., Hokamaki J., Miyamoto S., Kojima S., Shimomura H., Tsujita K., Sakamoto T., Yoshimura M., and Ogawa H. Urinary 8-hydroxy-2′-deoxyguanosine levels increase after reperfusion in acute myocardial infarction and may predict subsequent cardiac events. Am J Cardiol 95 (2005) 514-517
30. Reilly M.P., Delanty N., Roy L., Rokach J., Callaghan P.O., Crean P., Lawson J.A., and FitzGerald G.A. Increased formation of the isoprostanes IPF2alpha-I and 8-epi-prostaglandin F2alpha in acute coronary angioplasty: evidence for oxidant stress during coronary reperfusion in humans. Circulation 96 (1997) 3314-3320
31. Guan W., Osanai T., Kamada T., Ishizaka H., Hanada H., and Okumura K. Time course of free radical production after primary coronary angioplasty for acute myocardial infarction and the effect of vitamin C. Circ J 63 (1999) 924-928
32. Kijima Y., Hashimura K., Matsu-ura Y., Kato Y., Yasuda T., Ueda T., Orita Y., and Fukunaga M. Transcardiac 8-iso-prostaglandin F(2 alpha)generation from acute myocardial infarction heart: insight into abrupt reperfusion and oxidant stress. Prostaglandins Leukot Essent Fatty Acids 64 (2001) 161-166
33. Aukrust P., Ueland T., Müller F., Andreassen A.K., Nordøy I., Aas H., Kjekshus J., Simonsen S., Frøland S.S., and Gullestad L. Elevated circulating levels of C-C chemokines in patients with congestive heart failure. Circulation 97 (1998) 1136-1143
34. Yeh E.T. Life and death in the cardiovascular system. Circulation 95 (1997) 782-786
35. Buttke T.M., and Sandstrom P.A. Oxidative stress as a mediator of apoptosis. Immunol Today 15 (1994) 7-10
36. Satriano J.A., Shuldiner M., Hora K., Xing Y., Shan Z., and Schlondorff D. Oxygen radicals as second messengers for expression of the monocyte chemoattractant protein, JE/MCP-1, and the monocyte colony-stimulating factor, CSF-1, in response to tumor necrosis factor-alpha and immunoglobulin G. Evidence for involvement of reduced nicotinamide adenine dinucleotide phosphate (NADPH)-dependent oxidase. J Clin Invest 92 (1993) 1564-1571